• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. SYRINGE 10ML SALINE XS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. SYRINGE 10ML SALINE XS Back to Search Results
Catalog Number 306572
Device Problem Delivered as Unsterile Product (1421)
Patient Problem Sepsis (2067)
Event Date 09/21/2020
Event Type  Injury  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that the patient developed sepsis after using syringe 10ml saline xs.The following information was provided by the initial reporter: we have a customer complaint about the following product: ref 306572 / lot 0154145 the patient has developed sepsis after connecting the nutritional solution.We ask that the batch of bd posiflush be examined to determine if it could have been contaminated in order to rule it out as the cause.We ask for feedback after checking the batch.
 
Event Description
It was reported that the patient developed sepsis after using syringe 10ml saline xs.The following information was provided by the initial reporter: we have a customer complaint about the following product: ref (b)(4) / lot 0154145 the patient has developed sepsis after connecting the nutritional solution.We ask that the batch of bd posiflush be examined to determine if it could have been contaminated in order to rule it out as the cause.We ask for feedback after checking the batch.
 
Manufacturer Narrative
H6: investigation summary: a device history record review was performed for provided lot number 0154145 and the review did not reveal any detected quality issues during the production process that could have directly contributed to this reported incident.During the production process and during final inspection of the product, the sterile barrier integrity is confirmed at several points, endotoxin bioburden tests are taken to ensure sterility, and environmental monitoring of the saline fill room is performed bi-weekly.The lab results for this process were reviewed and all of the testing in place ensured that the product was fit for its intended use and met the standard requirements for the product.There is no evidence that posiflush syringe was responsible for the patient¿s infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYRINGE 10ML SALINE XS
Type of Device
SYRINGE
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key10659915
MDR Text Key214793674
Report Number9616657-2020-00161
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 11/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date05/31/2023
Device Catalogue Number306572
Device Lot Number0154145
Was Device Available for Evaluation? No
Date Manufacturer Received11/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-